Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Practice for Electronic Medical Device Management in Radiation Therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

The Epigenetic Regulator Histone Demethylase KDM5A is Activated and Pathogenic in a Mouse Model of Heart Failure.

bioRxiv : the preprint server for biology·2026
Same author

The Pathogenic Role of the DNA Double-Stranded Breaks in Hereditary Cardiomyopathies.

Heart failure clinics·2025
Same author

Self-DNA by Activating the CGAS-STING1 Pathway Contributes to the Pathogenesis of Atherosclerosis.

Current atherosclerosis reports·2025
Same author

Causes and consequences of DNA double-stranded breaks in cardiovascular disease.

Molecular and cellular biochemistry·2024
Same author

"The unbearable lightness" of the primary end point in clinical trials.

Molecular and cellular biochemistry·2024

Related Experiment Video

Updated: Jul 5, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Identifying modifier loci in existing genome scan data.

E W Daw1, Y Lu, A J Marian

  • 1Division of Statistical Genomics, Washington University School of Medicine, Saint Louis, MO 63108, USA. warwick@wustl.edu

Annals of Human Genetics
|May 23, 2008
PubMed
Summary
This summary is machine-generated.

Identifying secondary genetic modifier loci is possible by re-analyzing genome screen data. These methods offer new targets for screening and treatment in genetic disorders.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Related Experiment Videos

Last Updated: Jul 5, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Area of Science:

  • Genetics
  • Bioinformatics
  • Computational Biology

Background:

  • Genetic disorders often involve multiple genes, with primary disease loci and secondary modifier loci influencing trait variation.
  • Identifying modifier loci is crucial for understanding disease mechanisms and developing targeted therapies.

Purpose of the Study:

  • To test the hypothesis that secondary modifier loci can be identified by re-analyzing genome screen data while controlling for primary locus effects.
  • To evaluate the effectiveness of specific statistical methods in detecting modifier loci.

Main Methods:

  • Simulated genome screening data on real family structures for hypertrophic cardiomyopathy.
  • Modeled trait variations influenced by primary genes, secondary modifier genes, and gene-gene interactions.
  • Employed Monte Carlo Markov chain (MCMC) simultaneous segregation and linkage analysis (Loki) and LOD scores with individual-specific liability classes.

Main Results:

  • Both MCMC and LOD score methods identified significant secondary loci in some simulation replicates.
  • The analyses demonstrated the feasibility of mapping modifier loci by controlling for primary locus effects.

Conclusions:

  • Re-analysis of existing genome screen data can successfully identify modifier loci.
  • These methods provide valuable tools for genetic research and potential therapeutic target discovery.